ESMO Congress 2026
October 23–27, 2026 · Madrid · 4742 items
Madrid floor. One post is one item; several people on the same trial or drug become a heat probe.
After each Eastern day closes, the floor is filed as a daily. Named trials and drugs with a distinct trend, and with news, enter the site hot list; floor posts stay here.
ESMO 2026 · 26 Oct floor digest
1. tucatinib (15); 2. ARTEMIS-011 (13); 3. MOIO (13); 4. SANOVO (13); 5. TROFUSE-005 (12); 6. sacituzumab (11); 7. HER2 (10); 8. rezetecan (10)
- 01tucatinib15 peopledown
- 02ARTEMIS-01113 people
- 03MOIO13 peopledown
- 04SANOVO13 people
- 05TROFUSE-00512 peopledown
- 06sacituzumab11 peopledown
- 07HER210 peopledown
- 08rezetecan10 peopledown
- 09KRAS9 peopleup
- 10DESTINY-BREAST099 peopledown
- 11DELLPHI-3048 peopledown
- 12trastuzumab8 peopledown
- 13EGFR7 peopledown
- 14SAFFRON7 peopledown
- 15KEYNOTE-C937 peopledown
- 16DELLPHI-3056 peopledown
- 17MET6 peopledown
- 18ASTRIDE6 peopledown
- 19izalontamab6 people
- 20KRASCENDO5 peopledown
ESMO 2026 · 10 2026-10-25 floor digest
1. SAFFRON (36); 2. pembrolizumab (26); 3. HARMONI-GI1 (23); 4. KRASCENDO (22); 5. LITESPARK-011 (16); 6. KRASCENDO-1 (15); 7. ivonescimab (15); 8. LITESPARK-012 (15)
- 01SAFFRON36 peopledown
- 02pembrolizumab26 peopledown
- 03HARMONI-GI123 peopledown
- 04KRASCENDO22 peopledown
- 05LITESPARK-01116 peopledown
- 06KRASCENDO-115 peopledown
- 07ivonescimab15 peopledown
- 08LITESPARK-01215 peopledown
- 09EGFR14 peopledown
- 10docetaxel14 peopledown
- 11CLARITY-GASTRIC0113 peopledown
- 12DELLPHI-30511 peopledown
- 13divarasib11 peopledown
- 14KRAS10 peopledown
- 15INTERPATH-0019 peopledown
- 16VOLGA9 peopledown
- 17HER29 peopledown
- 18sacituzumab9 peopledown
- 19NATALEE7 peopledown
- 20dostarlimab7 peopledown
ESMO 2026 · 10 2026-10-24 floor digest
1. DELLPHI-305 (53); 2. VOLGA (42); 3. INTERPATH-001 (33); 4. tarlatamab (21); 5. durvalumab (21); 6. FOURLIGHT-1 (19); 7. DASL-HICAP (17); 8. POSTMONARCH (16)
- 01DELLPHI-30553 peopledown
- 02VOLGA42 peopledown
- 03INTERPATH-00133 peopledown
- 04tarlatamab21 peopledown
- 05durvalumab21 peopledown
- 06FOURLIGHT-119 peopledown
- 07DASL-HICAP17 people
- 08POSTMONARCH16 peopledown
- 09HER215 peopledown
- 10KEYNOTE-B4915 peopledown
- 11JNJ-614313 peopledown
- 12paclitaxel12 peopledown
- 13#PROSTATECANCER9 peopledown
- 14anbenitamab9 peopledown
- 15osimertinib9 peopledown
- 16NATALEE8 peopledown
- 17pembrolizumab7 peopledown
- 18ipatasertib7 people
- 19POTOMAC7 people
- 20lorlatinib7 peopledown
ESMO 2026 · 10 2026-10-23 floor digest
1. NATALEE (28); 2. HER2 (22); 3. KEYNOTE-866 (21); 4. TALENT (17); 5. PANKU-BREAST01 (16); 6. KEYNOTE-B15 (13); 7. nivolumab (13); 8. HORIZON-BREAST06 (12)
- 01NATALEE28 peopledown
- 02HER222 peopledown
- 03KEYNOTE-86621 peopledown
- 04TALENT17 peopledown
- 05PANKU-BREAST0116 peopledown
- 06KEYNOTE-B1513 peopledown
- 07nivolumab13 peopledown
- 08HORIZON-BREAST0612 peopledown
- 09daraxonrasib11 peopledown
- 10pembrolizumab11 peopledown
- 11trastuzumab11 peopledown
- 12#BREASTCANCER10 peopledown
- 13SANO9 peopledown
- 14KEYNOTE-9059 peopledown
- 15docetaxel9 peopledown
- 16HERIZON-GEA8 peopledown
- 17#PROSTATECANCER8 peopledown
- 18DELLPHI-3057 peopleup
- 19CAPITELLO-2817 peopleup
- 20MASTERPLAN7 peopledown